<DOC>
	<DOCNO>NCT01613066</DOCNO>
	<brief_summary>Cord blood ( CB ) unrelated donor increasingly used alternative source hematopoietic stem cell adult hematologic malignancy lack HLA-matched donor . However , utilization single-unit CB transplantation adult patient impede low number nucleate cell available individual CB unit . Direct intrabone CB injection ( IBCBi ) recently investigate solution cell dose problem adult , aim minimize non-specific loss progenitor . We set phase I-II study ass safety efficacy CB transplantation IBCBi adult patient advance high-risk hematological malignancy</brief_summary>
	<brief_title>Intra-bone Cord Blood Transplantation Patients With Haematological Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<criteria>Advanced High Risk Haematological Malignancies Age 1865 year suitable unrelated HLAmatched donor identify clinically useful timeframe Informed consent Active infectious disease inclusion HIV positivity active hepatitis infection Impaired liver function ( Bilirubin &gt; upper normal limit ; Transaminases &gt; 3.0 x upper normal limit ) inclusion Impaired renal function ( Creatinineclearance &lt; 60 ml/min ; Serum Creatinine &gt; 1.5 x upper normal limit ) inclusion Psychiatric diseases condition might impair ability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Haematological malignancy</keyword>
	<keyword>Allogeneic Cord Blood transplantation</keyword>
	<keyword>Intrabone</keyword>
</DOC>